May 28th 2025
These data are intended to support a new drug application to the FDA in the second half of 2025.
Low retreatment rates observed for SUI procedures
September 17th 2013Three different procedures to treat stress urinary incontinence led to high rates of recurrence-free outcomes at 5 years, and the choice of retreatment of SUI varied according to the initial procedure, long-term follow-up in two randomized trials showed.
Need for post-sling voiding trial may be beneficial
September 17th 2013Need for a repeat voiding trial after midurethral sling surgery does not increase the likelihood of a suboptimal outcome and may even predict a better long-term result, say researchers from the Urinary Incontinence Treatment Network.
Advances in TURP: Focus on the science
September 1st 2013Most urologists agree that surgical removal of the enlarged portion of the prostate is the most effective and durable way to manage lower urinary tract symptoms in men secondary to BPH. Where it gets interesting is deriving urologic consensus on the best way to achieve that goal.
Testosterone doesn’t worsen lower urinary tract symptoms in men with BPH
September 1st 2013A new study has found that testosterone replacement doesn’t worsen lower urinary tract symptoms related to an enlarged prostate. In fact, many men saw their symptoms improve, apparently with little effect on their prostate gland.
Plasma vaporization found superior to TURis, TURP for BPH
August 9th 2013As follow-up lengthens in a prospective, randomized, controlled trial, men who underwent bipolar plasma vaporization of the prostate for BPH using the “button” vapo-resection electrode continue to demonstrate significantly better symptom scores and voiding characteristics compared to their counterparts treated by bipolar transurethral resection in saline or monopolar transurethral resection of the prostate.
For BPH, bipolar, monopolar transurethral resection of the prostate show similar clinical efficacy
August 9th 2013In the treatment of BPH, while both bipolar-transurethral resection of the prostate (B-TURP) and monopolar-TURP (M-TURP) have similar clinical efficacy, B-TURP is associated with fewer adverse events, according to a recent systematic review of the two modalities.
Kidney stones linked to heart disease risk in women
July 29th 2013An analysis of data from three studies that involved a total of more than 240,000 participants found that a self-reported history of kidney stones was associated with a statistically significant increased risk of coronary heart disease among women.
Reduced OR, laser time observed with newer PVP system
May 24th 2013The new-generation GreenLight XPS-180W laser system (American Medical Systems, Minnetonka, MN) achieved an improved rate of tissue vaporization and overall efficacy in patients with BPH compared to an earlier generation laser, according to results of a recent multicenter study.
AUA 2013: Newer OAB agent viable alternative to antimuscarinics
May 7th 2013Data from a recent multicenter study provide new evidence that the beta-3 adrenoceptor agonist mirabegron (Myrbetriq) appears to be a viable alternative in patients with overactive bladder (OAB) who are poor responders to antimuscarinic agents or intolerant of their adverse events.
AUA 2013: ‘Lift’ procedure shows durable improvement in LUTS
May 7th 2013Men with symptomatic BPH had statistically significant, durable improvement in lower urinary tract symptoms (LUTS) following an office-based, minimally invasive prostatic urethral lift procedure, results of a pivotal randomized trial showed.